Special Drug Use Investigation for PAXIL Tablet (20mg-Clinical Symptom Progression)
Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
Overall improvement, severities and changes of specific clinical symptoms were surveyed in
outpatients with depression or in a depressed state to evaluate the efficacy and safety of
PAXIL tablets in patients in whom the PAXIL dose was increased and those treated with a
constant dose.